79. Roberts H, Kruszon-Moran D, Ly KN, Hughes
E, Iqbal K, Jiles RB, et al. Prevalence of chronic
hepatitis B virus (HBV) infection in U.S. households:
National Health and Nutrition Examination Survey
(NHANES), 1988-2012. Hepatology 2016;63:388–97.
80. Welzel TM, Graubard BI, Quraishi S, Zeuzem
S, Davila JA, El-Serag HB, et al. Population-attributable fractions of risk factors for hepatocellular
carcinoma in the United States. Am J Gastroenterol
81. Accelerating HPV Vaccine Uptake: Urgency for
Action to Prevent Cancer. A Report to the President
of the United States from the President’s Cancer Panel.
Bethesda, MD: National Cancer Institute; 2014.
82. Reagan-Steiner S, Yankey D, Jeyarajah J, Elam-Evans
LD, Singleton JA, Curtis CR, et al. National, regional,
state, and selected local area vaccination coverage
among adolescents aged 13-17 years—United States,
2014. MMWR Morb Mortal Wkly Rep 2015;64:784–92.
83. Binagwaho A, Wagner CM, Gatera M, Karema
C, Nutt CT, Ngabo F. Achieving high coverage in
Rwanda's national human papillomavirus vaccination
programme. Bull World Health Organ 2012;90:623–8.
84. Raesima MM, Forhan SE, Voetsch AC, Hewitt S,
Hariri S, Wang SA, et al. Human papillomavirus
vaccination coverage among school girls in a
demonstration project—Botswana, 2013. MMWR
Morb Mortal Wkly Rep 2015;64:1147–9.
85. National Vaccine Advisory committee. Overcoming
Barriers to Low HPV Vaccine Uptake in the United
States: Recommendations from the National Vaccine
Advisory Committee: Approved by the National
Vaccine Advisory Committee on June 9, 2015. Public
Health Rep 2016;131: 17–25.
86. Gilkey MB, Malo TL, Shah PD, Hall ME, Brewer
NT. Quality of physician communication about
human papillomavirus vaccine: findings from a
national survey. Cancer Epidemiol Biomarkers Prev
87. Cantley LC, Dalton WS, DuBois RN, Finn OJ, Futreal
PA, Golub TR, et al. AACR Cancer Progress Report
2012. Clin Cancer Res 2012;18:S1–100.
88. National ToxicologyProgram.ReportonCarcinogens,
13th Edition. Research Triangle Park, NC: U.S.
Department of Health and Human Services, Public
Health Service; 2014. Available from: http://ntp.
89. National Cancer Institute. Radon and Cancer. 2011
cited 2016 July 31; Available from: http://www.
90. Loomis D, Grosse Y, Lauby-Secretan B, El Ghissassi
F, Bouvard V, Benbrahim-Tallaa L, et al. The
carcinogenicity of outdoor air pollution. Lancet
91. Baris D, Waddell R, Beane Freeman LE, Schwenn M,
Colt JS, Ayotte JD, et al. Elevated bladder cancer in
Northern New England: the role of drinking water
and arsenic. J Natl Cancer Inst 2016; 108.
92. Blake JM, Avasarala S, Artyushkova K, Ali AM,
Brearley AJ, Shuey C, et al. Elevated concentrations
of U and co-occurring metals in abandoned mine
wastes in a northeastern Arizona Native American
community. Environ Sci Technol 2015;49:8506–14.
93. Kensler T W, Spira A, Garber JE, Szabo E, Lee JJ, Dong
Z, et al. Transforming cancer prevention through
precision medicine and immune-oncology. Cancer
Prev Res (Phila) 2016;9: 2–10.
94. Borras E, San Lucas FA, Chang K, Zhou R, Masand
G, Fowler J, et al. Genomic landscape of colorectal
mucosa and adenomas. Cancer Prev Res (Phila)
95. Levy AR, Bruen BK, Ku L. Health care reform and
women's insurance coverage for breast and cervical
cancer screening. Prev Chronic Dis 2012;9:E159.
96. Lindor NM, McMaster ML, Lindor CJ, Greene MH.
Concise Handbook of Familial Cancer Susceptibility
Syndromes—Second Edition. JNCI Monographs
97. Spechler SJ. Barrett esophagus and risk of esophageal
cancer: a clinical review. JAMA 2013;310:627–36.
98. Mattar MC, Lough D, Pishvaian MJ, Charabaty
A. Current management of inflammatory bowel